Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Merck & Co. discloses beta-lactamase inhibitors

Aug. 13, 2015

CMC Biologics to develop and manufacture MAbs for PATH Malaria Vaccine Initiative

Aug. 13, 2015

Ceftobiprole receives FDA QIDP designation for lung and skin infections

Aug. 13, 2015

DSMB recommends continuation of phase I trial of ContraFect's CF-301

Aug. 12, 2015

Novavax reports phase II results for RSV vaccine in older adults

Aug. 12, 2015

Nabriva divulges mutilin derivatives

Aug. 12, 2015

Turing acquires Daraprim U.S. rights from Impax

Aug. 11, 2015

Novel potent cross-reactive MAb that neutralizes influenza A virus

Aug. 11, 2015

Antiva Biosciences raises funds to advance lead compound for HPV

Aug. 10, 2015

Sunshine Lake patents HCV NS5A inhibitors

Aug. 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...